BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3934648)

  • 1. Lack of effect of thyrotropin releasing hormone (TRH) in circulatory shock.
    Hock CE; Lefer AM
    Peptides; 1985; 6(3):547-53. PubMed ID: 3934648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin-releasing hormone (TRH) and circulatory shock.
    McIntosh TK; Faden AI
    Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J; Hock CE; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):360-5. PubMed ID: 6728045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of AVP in maintenance of circulatory homeostasis during hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Am J Physiol; 1984 Feb; 246(2 Pt 2):H174-9. PubMed ID: 6696129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial actions of thromboxane receptor antagonism in hemorrhagic shock.
    Bitterman H; Yanagisawa A; Lefer AM
    Circ Shock; 1986; 20(1):1-11. PubMed ID: 2945667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salutary effects of nitrendipine, a new calcium entry blocker, in hemorrhagic shock.
    Hock CE; Su JY; Lefer AM
    Eur J Pharmacol; 1984 Jan; 97(1-2):37-46. PubMed ID: 6698110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ; Holaday JW; Reynolds DG; Ganes E
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
    Sugiura A; Smith RA; Shatney CH
    J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of thyrotropin-releasing hormone in canine hemorrhagic shock.
    Teba L; Zakaria M; Dedhia HV; Schiebel F; Beamer KC
    Circ Shock; 1987; 21(1):51-7. PubMed ID: 2949884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effect of arachidonic acid during hemorrhagic shock in the dog.
    Flynn JT; Lefer AM
    Circ Res; 1977 Apr; 40(4):422-8. PubMed ID: 844155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial mechanisms of action of a prostacyclin enhancing agent in splanchnic artery occlusion shock.
    Aoki N; Siegfried M; Tsao P; Lento P; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1988 Jun; 60(3):275-89. PubMed ID: 3175328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effect of thyrotropin-releasing hormone in combination with HSD on hemorrhagic shock with pulmonary edema at high altitude in the rat].
    Hu DY; Liu LM; Li P; Liu JC; Liu HD; He YM; Huo XP; Tian KL; Shi QG; Xiao N; Zhou XW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 May; 15(5):268-71. PubMed ID: 12837184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of thyrotropin-releasing hormone in experimental hemorrhagic shock--cardiovascular mechanism.
    Zheng D; Chen HS; Hu DY
    J Tongji Med Univ; 1990; 10(3):187-92. PubMed ID: 1979356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyrotropin releasing hormone analogue, RGH 2202, reverses experimental haemorrhagic shock in rats.
    Coppi G; Falcone A
    Eur J Pharmacol; 1990 Jun; 182(1):185-8. PubMed ID: 2119310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG; Hock CE; Edmonds JS; Lefer AM
    J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salutary effects of CG-4203, a novel, stable prostacyclin analog, in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer DJ; Lefer AM
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):293-9. PubMed ID: 2464101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of hypertonic saline in the treatment of hemorrhagic shock.
    Bitterman H; Triolo J; Lefer AM
    Circ Shock; 1987; 21(4):271-83. PubMed ID: 3581442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
    Aoki N; Johnson G; Lefer AM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of thyrotropin-releasing hormone against lipid peroxidation injury during traumatic shock in rats].
    Chen H
    Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):438-40, 32. PubMed ID: 1660763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.